Register
Forgot your password?

Epicardial implantable cardioverter-defibrillator system placed in children with Jervell–Lange-Nielsen syndrome

Authors: Marchenko A.V. 1, Shekhmamet’ev R.M. 1, Vronskiy A.S. 2, Koryagina N.A. 2, Myalyuk P.A. 1, Nekrasova A.N .1

Company: 1 Federal Centre of Cardiovacular Surgery named after S.G. Sukhanov, Perm’, 614000, Russian Federation
2 Perm State Medical University named after academician E.A. Wagner, Perm’, 614013, Russian Federation

For correspondence:  Sign in or register.

Type:  Case reports


DOI: https://doi.org/10.24022/ 1997-3187-2020-14-1-82-92

For citation: Marchenko A.V., Shekhmamet’ev R.M., Vronskiy A.S., Koryagina N.A., Myalyuk P.A., Nekrasova A.N. Epicardial implantable cardioverter-defibrillator system placed in children with Jervell–Lange-Nielsen syndrome. Creative Cardiology. 2020; 14 (1): 82–92 (in Russ.). DOI: 10.24022/1997-3187-2020-14-1-82-92

Received / Accepted:  21.02.2020 / 27.02.2020

Keywords: long Q–T syndrome cardioverter-defibrillator system epicardial implantable syncope

Full text:  

 

Abstract

We presents a clinical case of girls 12 and 9 years old with long Q–T syndrome. Based on the data of the anamnesis, sudden death of a relative at the age of 40, sudden death of a younger brother at the age of 7, closely related parents marriage, laboratory and instrumental examinations, objective examination, as well as congenital deafmutism in girls, a rare hereditary Jervell and Lange-Nielsen syndrome has been identified. Both girls took anaprilin, while in the older patient, during therapy, syncope attacks associated with physical and emotional stress were noted. Based on clinical recommendations, as well as data from major studies, it was decided to implant a cardioverter defibrillator on both girls. The postoperative period was uneventful, patients were discharged under the supervision of a pediatric cardiologist with recommendations: taking anaprilin 6.5 mg 4 times a day, magnesium preparations 1 tablet 3 times a day for life. Patients were dynamically observed throughout the year. The elder sister, 12 years old, 4 and 9 months after the operation, triggered a cardioverter-defibrillator due to ventricular tachycardia. Actual data of epidemiology, etiology, pathogenesis of the disease, as well as a discussion based on these recommendations and major literature analyzes are presented.

References

  1. Jervell A., Lange-Nielsen F. Congenital deafmutism, functional heart disease with prolongation of the QT interval and sudden death. Ann. NY Acad. Sci. 1992; 644: 142–57.
  2. Romano C., Gemme G., Pongiglione R. Aritmie cardiache rare dell'eta pediatrica. Clin. Pediatr. (Bologna). 1963; 45: 656–83.
  3. Ward O.C. New familiar cardiac syndrome in children. J. Irish. Med. Assoc. 1964; 54: 103–6.
  4. London B. Overview of inherited diseases that predispose of the development of cardiac arrythmias (LQTS, ARVD, AF. Brugada). North America Society of Pacing and Electrophysiology (NASPE). 21st Annual Scientific Sessions. 2010.
  5. Fraser G.R., Froggat P., Murphy T. Genetics aspects of the cardioauditory syndrome of Jervell and Lange-Nielsen (congenital deafness and electrocardiographic abnormalities). Ann. Hum. Genet. 1964; 28: 133–57.
  6. Khlynova O.V., Vasilets L.M., Tuev A.V. Hereditary arrhythmological syndromes: principles of diagnosis and treatment. Moscow; 2018 (in Russ.).
  7. Schwartz P.J., Spazzolini C., Crotti L. et al. Jervell and Lange-Nielsen Syndrome. Circulation. 2006; 113: 783–90.
  8. Schwartz P.J., Moss A.J., Vincent G.M., Crampton R.S. Diagnostic criteria for the long QT syndrome. An update. Circulation. 1993; 88: 782–4. DOI: 10.1161/01.CIR.88.2.782
  9. Schwartz P.J., Crotti L. QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation. 2011; 124 (20): 2181–4. DOI: 10.1161/CIRCULATIONAHA.111.062182
  10. Sy R.W., van der Werf C., Chatta I.S., Chockalingam P., Adler A., Healey J.S. et al. Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands. Circulation. 2011; 124: 2187–94.
  11. Giudicessi J.R., Ackerman M.J. Genotype- and phenotyped-guided management of congenital long QT syndrome Curr. Probl. Cardiol. 2013; 38 (10): 417–55. DOI:10.1016/j.cpcardiol.2013.08.001
  12. Golukhova E.Z., Gromova O.I., Shomakhov R.A., Bulaeva N.I., Bockeria L.A. Monogenic arrhythmic syndromes: from molecular genetic aspects to the patient's bed. Acta Naturae. 2016; 8 (2): 70–83 (in Russ.).
  13. Priori S.G., Blomström-Lundqvist C., Mazzanti A., Blom N., Borggrefe M., Camm J. et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Eur. Heart J. 2015; 36 (41): 2793–867. DOI: 10.1093/eurheartj/ehv316
  14. Clinical recommendations: long QT interval syndrome. Approved by the Union of Pediatricians of Russia, the Association of Pediatric Cardiologists of Russia. 2016 (in Russ.).
  15. Viskin S., Postema P.G., Bhuiyan Z.A., Rosso R., Kalman J.M., Vohra J.K. et al. The response of the QT interval to the brief tachycardia provoked by standing: A bedside test for diagnosing long QT syndrome. JACC. 2010; 55 (18): 1955–61.
  16. Adler A., van der Werf C., Postema P.G., Rosso R., Bhuiyan Z.A., Kalman J.M. et al. The phenomenon of 'QT stunning': the abnormal QT prolongation provoked by standing persists even as the heart rate returns to normal in patients with long QT syndrome. Heart Rhythm. 2012; 9 (6): 901–8.
  17. Bhuiyan Z.A., Al-Shahrani S., Al-Aama J., Wilde A.A.M., Momenah T.S. Congenital long QT syndrome: an update and present perspective in Saudi Arabia. Front. Pediatr. 2013; 1: 39. DOI: 10.3389/fped.2013.00039
  18. Border W.L., Benson D.W. Sudden infant death syndrome and long QT syndrome: the zealots versus the naysayers. Heart Rhythm. 2007; 4 (2): 167–9.
  19. Kushakovskiy M.S. Arrhythmias of the heart. Guide for doctors. Saint-Petersburg; 1998 (in Russ.).
  20. Yanushkevichus Z.I., Bredikis Yu.Yu., Lukoshyavichyute A.Y., Zabela P.V. Violation of the rhythm and conduction of the heart. Moscow; 1984 (in Russ.).
  21. Vos M.A., Goorenek B., Verduyn S.C. et al. Observations on the onset of torsade de pointes arrythmias 23 in the acquired long QT syndrome. Cardivasc. Res. 2000; 48 (3): 421–9.
  22. Crotti L., Johnson C.N., Graf E. et al. Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation. 2013; 127: 1009–17.
  23. Wang F., Liu J., Hong L. et al. The phenotype characteristics of type 13 long QT syndrome with mutation in KCNJ5 (Kir3.4-G387R). Heart Rhythm. 2010; 10: 1500–6.
  24. Roden D.M., Lazzara R., Rosen M. et al. Multiple mechanisms in the Long-QT syndrome. Current knowledge, gaps and future direcrions. Circulation. 1996; 94: 1996–2012.
  25. Schwartz P.J. Idiopathic long QT syndrome: progress and questions. Am. Heart J. 1985; 109 (2): 399–411.
  26. Bockeria O.L., Sanakoev M.K. Long Q-T Interval Syndrome. Annaly Aritmologii (Annals of Arrhythmology). 2015; 12 (2): 114–27 (in Russ.).

About Authors

  • Andrey V. Marchenko, Dr. Med. Sc., Cardiovascular Surgeon, ORCID
  • http:// Roman M. Shekhmamet’ev, Head of Department, ORCID
  • Aleksey S. Vronskiy, Resident Physician, ORCID
  • Natal’ya A. Koryagina, Dr. Med. Sc., Professor, ORCID
  • Pavel A. Myalyuk, Cardiovascular Surgeon, ORCID
  • Anna N. Nekrasova, Cardiologist-Arrhythmologist, ORCID

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by